BioDlink
东曜药业 (BioDlink) offers Antibody and ADC characterization, higher-order structure and comparability. This is the analytical service business of an integrated CRO/CDMO.
Corporate information
- Company entity
- 东曜药业 (BioDlink)
- Ownership / capital status
- Group subsidiary / business platformWuXi XDC controlled subsidiary ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗
- Official corporate reference
- https://biodlink.com/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-05 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Start with public sources and capability boundaries; company claims are not independent certification.
Ask AI ↗Public evidence snapshot
东曜药业 (BioDlink) offers Antibody and ADC characterization, higher-order structure and comparability. This is the analytical service business of an integrated CRO/CDMO.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.